Latest & greatest articles for thyroid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on thyroid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on thyroid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for thyroid

1. AAES Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults

AAES Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults The American Association of Endocrine Surgeons Guidelines fo... : Annals of Surgery ')} You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Your account has been temporarily locked Your account has been temporarily locked due to incorrect sign in attempts and will be automatically unlocked in 30 mins. For immediate assistance, contact Customer (...) served as a consultant for Veracyte. The authors report no conflicts of interest. Annals of Surgery: doi: 10.1097/SLA.0000000000003580 Free Metrics Abstract Objective: To develop evidence-based recommendations for safe, effective, and appropriate thyroidectomy. Background: Surgical management of thyroid disease has evolved considerably over several decades leading to variability in rendered care. Over 100,000 thyroid operations are performed annually in the US. Methods: The medical literature from 1

2021 Publication 4896149

2. Selpercatinib (Retsevmo) for the treatment of RET-fusion positive NSCLC, RET-fusion positive thyroid cancer and RET-mutant medullary-thyroid cancer

Selpercatinib (Retsevmo) for the treatment of RET-fusion positive NSCLC, RET-fusion positive thyroid cancer and RET-mutant medullary-thyroid cancer Selpercatinib (Retsevmo®) for the treatment of RET-fusion positive NSCLC, RET-fusion positive thyroid cancer and RET-mutant medullary-thyroid cancer - Repository of AIHTA GmbH English | Browse - - - Selpercatinib (Retsevmo®) for the treatment of RET-fusion positive NSCLC, RET-fusion positive thyroid cancer and RET-mutant medullary-thyroid cancer (...) Grössmann, N. (2020): Selpercatinib (Retsevmo®) for the treatment of RET-fusion positive NSCLC, RET-fusion positive thyroid cancer and RET-mutant medullary-thyroid cancer. Oncology Fact Sheet Nr. 36. Preview - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. , oder 87kB Item Type: Oncology Fact Sheet Subjects: > > > > Language: English Series Name: Oncology Fact Sheet Nr. 36 Deposited on: 04 Jan 2021 14:13 Last Modified: 04 Jan 2021 16:33 Repository Staff Only: © Copyright ,

2021 Austrian Institute of Health Technology Assessment

3. Thyroid Dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis Full Text available with Trip Pro

Thyroid Dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis Inplasy Protocol 856 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

4. Thyroid Disease and Infertility

Thyroid Disease and Infertility Committee Opinion No. 407: Thyroid Disease and Infertility - Journal of Obstetrics and Gynaecology Canada Go search , P1279-1282, October 01, 2020 Powered By Mendeley Share on Committee Opinion No. 407: Thyroid Disease and Infertility Lois Donovan Correspondence Corresponding Author: Lois Donovan Affiliations Calgary, AB Heather Cockwell Affiliations Halifax, NS Niamh Tallon Affiliations Vancouver, BC Jennifer Yamamoto Affiliations Calgary, AB DOI: (En français (...) : Pathologie thyroïdienne et infertilité) Keywords To read this article in full you will need to make a payment Already a print subscriber? Already an online subscriber? Register: Institutional Access: REFERENCES Alexander EK Pearce EN Brent GA et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27 : 315-389 Practice Committee of the American Society for Reproductive Medicine Subclinical

2020 Society of Obstetricians and Gynaecologists of Canada

5. The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis Full Text available with Trip Pro

The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis | SpringerLink Search Search SpringerLink Search The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis The ultrasound risk stratification systems for thyroid nodule have (...) been evaluated against papillary carcinoma. A meta-analysis , , , , , , , & ( 2020 ) 516 Accesses Abstract Thyroid imaging reporting and data systems (TIRADS) are used to stratify the malignancy risk of thyroid nodule by ultrasound (US) examination. We conducted a meta-analysis to evaluate the pooled cancer prevalence and the relative prevalence of papillary, medullary, follicular thyroid cancer (PTC, MTC, and FTC) and other malignancies among nodules included in studies evaluating

2020 Reviews in Endocrine and Metabolic Disorders

6. Potential Values Of Circulating Tumor Cell For Detection Of Recurrence In Patients Of Thyroid Cancer:A Diagnostic Meta-analysis Full Text available with Trip Pro

Potential Values Of Circulating Tumor Cell For Detection Of Recurrence In Patients Of Thyroid Cancer:A Diagnostic Meta-analysis Potential Values Of Circulating Tumor Cell For Detection Of Recurrence In Patients Of Thyroid Cancer:A Diagnostic Meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Cancer . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Potential Values Of Circulating Tumor Cell For Detection Of Recurrence In Patients Of Thyroid Cancer:A Diagnostic Meta-analysis Ming-Xing Liang, Yin-Jiao Fei, Kai Yang, Wen-Juan Tang, Xin-Hui Cao, Jinhai Tang Ming-Xing Liang Nanjing Medical University Yin

2020 Research Square

7. Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid Cancers. (Abstract)

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. RET mutations occur in 70% of medullary thyroid cancers, and RET fusions occur rarely in other thyroid cancers. In patients with RET-altered thyroid cancers, the efficacy and safety of selective RET inhibition are unknown.We enrolled patients with RET-mutant medullary thyroid cancer with or without previous vandetanib or cabozantinib treatment, as well as those with previously treated RET fusion-positive thyroid cancer, in a phase (...) 1-2 trial of selpercatinib. The primary end point was an objective response (a complete or partial response), as determined by an independent review committee. Secondary end points included the duration of response, progression-free survival, and safety.In the first 55 consecutively enrolled patients with RET-mutant medullary thyroid cancer who had previously received vandetanib, cabozantinib, or both, the percentage who had a response was 69% (95% confidence interval [CI], 55 to 81), and 1-year

2020 NEJM

8. The diagnostic accuracy of superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta analysis Full Text available with Trip Pro

The diagnostic accuracy of superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta analysis Inplasy Protocol 682 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

9. Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies Full Text available with Trip Pro

Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint (...) on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies Junyu Zhao, Jing Wen, Shengnan Wang, Jinming Yao, Lin Liao, Jianjun Dong Junyu Zhao The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong University Jing Wen Shandong

2020 Research Square

10. Thyroid cancer: NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic

Thyroid cancer: NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic Version: 1 Department: NCCP Radiation Oncology Working Group Update date: 22/04/2020 Code: RO_COVID19_6 Page 1 of 3 NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic This document relates (...) ://www.gov.ie/en/campaigns/c36c85-covid-19- coronavirus/ ? Ireland’s National Action Plan in response to COVID-19 (Coronavirus) - https://www.gov.ie/en/campaigns/c36c85-covid-19-coronavirus/ 2 Purpose The purpose of this guidance document is to provide guidance to medical professionals on the management of patients with 1) Thyroid cancer (well differentiated, papillary carcinoma) and 2) Patients with overactive thyroid disease. Version: 1 Department: NCCP Radiation Oncology Working Group Update date: 22/04

2020 Health Service Executive (Ireland) - Clinical Guidelines

11. Selpercatinib (Retevmo) - lung and thyroid cancers

Selpercatinib (Retevmo) - lung and thyroid cancers Drug Approval Package: RETEVMO U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: RETEVMO Company: Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company. Application Number: 213246 Approval Date: 05/08/2020 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF) (PDF) FDA Application Review

2020 FDA - Drug Approval Package

12. The value of TI-RADS combined with superb microvascular imagine in distinguishing thyroid nodules: A protocol for systematic review and meta-analysis Full Text available with Trip Pro

The value of TI-RADS combined with superb microvascular imagine in distinguishing thyroid nodules: A protocol for systematic review and meta-analysis Inplasy Protocol 577 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

13. Impact of thyroid ultrasonography combined ultrasound-guided fine-needle aspiration biopsy in detection thyroid microcarcinoma: A protocol of systematic review Full Text available with Trip Pro

Impact of thyroid ultrasonography combined ultrasound-guided fine-needle aspiration biopsy in detection thyroid microcarcinoma: A protocol of systematic review Inplasy Protocol 512 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

14. Association of Thyroid Hormone Therapy with Mortality in Adults with Subclinical Hypothyroidism: A systematic review and meta-analysis Full Text available with Trip Pro

Association of Thyroid Hormone Therapy with Mortality in Adults with Subclinical Hypothyroidism: A systematic review and meta-analysis Inplasy Protocol 436 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

15. Elastography reduces over-medical procedures in thyroid nodules: a systematic review and meta-analysis Full Text available with Trip Pro

Elastography reduces over-medical procedures in thyroid nodules: a systematic review and meta-analysis Elastography reduces over-medical procedures in thyroid nodules: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should (...) not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Elastography reduces over-medical procedures in thyroid nodules: a systematic review and meta-analysis Kun Yan, Wei Cheng, jiancang Ma, donggang Han, Xin Xu, Yanni Chen, Jie Li, Yiming Li, Zhiliang Wang, Pengyuan Jie Kun Yan the Second Affiliated Hospital of Medical College, Xi’an Jiaotong University Corresponding Author Wei Cheng xi'an children hospital

2020 Research Square

16. Anti-thyroid drug use during the first trimester of pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations Full Text available with Trip Pro

Anti-thyroid drug use during the first trimester of pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations Anti-thyroid drug use during the first trimester of pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations | medRxiv Search for this keyword Anti-thyroid drug use during the first trimester of pregnancy (...) . Nordeng 2 PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo , Oslo, Norway 3 Department of Child Development and Health, Norwegian Institute of Public Health , Oslo, Norway ABSTRACT Background Maternal anti-thyroid drug (ATD) use during the first trimester of pregnancy has been associated with an increased risk of birth defects in offspring. Uncertainty remains

2020 Cold Spring Harbor Laboratory

17. Thyroid hormone treatment: no proof of benefit in asymptomatic subclinical hypothyroidism.

Thyroid hormone treatment: no proof of benefit in asymptomatic subclinical hypothyroidism. Prescrire IN ENGLISH - Spotlight ''Thyroid hormone treatment: no proof of benefit in asymptomatic subclinical hypothyroidism.'', 1 June 2020 {1} {1} {1} | | > > > Thyroid hormone treatment: no proof of benefit in asymptomatic subclinical hypothyroidism. Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |  (...)  |   |   |  Spotlight Thyroid hormone treatment: no proof of benefit in asymptomatic subclinical hypothyroidism. According to a systematic review of comparative trials in approximately 2 000 patients, symptomless hypothyroidism discovered incidentally does not require thyroid hormone treatment (levothyroxine). So-called subclinical hypothyroidism is characterised by an elevated blood level of the pituitary hormone TSH but with a normal blood concentration of the thyroid

2020 Prescrire

18. Thyroid Disease in Pregnancy

Thyroid Disease in Pregnancy Thyroid Disease in Pregnancy | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Thyroid Disease in Pregnancy Practice Bulletin Number 223 June 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. Nonmembers: Subscribe now to access exclusive ACOG Clinical content, including: ACOG Clinical is designed for easy and convenient access (...) and clinical management issues. Note for Life Fellows: Annual membership dues are waived but there is a discounted annual subscription fee of $95 for access to publications such as the Green Journal, Practice Bulletins, and Committee Opinions. Individual subscriptions include print and online access. . Jump to: Figures & Tables Figure 1. Clinical Algorithm for Management of Thyroid Disease in Pregnancy. Abbreviations: T 3 , triiodothyronine; T 4 , thyroxine; TRAB, thyroid receptor antibodies; TSH, thyroid

2020 American College of Obstetricians and Gynecologists

19. Deep Learning Applications in Analyzing Ultrasound Images of Thyroid Nodules: Protocol for a Systematic Review Full Text available with Trip Pro

Deep Learning Applications in Analyzing Ultrasound Images of Thyroid Nodules: Protocol for a Systematic Review Deep Learning Applications in Analyzing Ultrasound Images of Thyroid Nodules: Protocol for a Systematic Review | Sharifi | Frontiers in Health Informatics Hamara Journals Frontiers in Health Informatics Menu Bar LINKS ISSUES Article Tools Email this article (Login required) Email the author (Login required) About The Authors Yasaman Sharifi Ph.D. Student of Medical Informatics (...) Sargolzaei Assistant Professor, Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Islamic Republic of Information Journal Content Search Scope Search Browse Deep Learning Applications in Analyzing Ultrasound Images of Thyroid Nodules: Protocol for a Systematic Review Yasaman Sharifi , Saeed Eslami HassanAbady, Morteza Danai Ashgzari, Mahdi Sargolzaei 108 Views Abstract Introduction: Ultrasound images are one of the main contributors

2020 Frontiers in Health Informatics

20. Impact of Gross Strap Muscle Invasion on Outcome of Differentiated Thyroid Cancer: Systematic Review and Meta-Analysis Full Text available with Trip Pro

Impact of Gross Strap Muscle Invasion on Outcome of Differentiated Thyroid Cancer: Systematic Review and Meta-Analysis Impact of Gross Strap Muscle Invasion on Outcome of Differentiated Thyroid Cancer: Systematic Review and Meta-Analysis[v1] | Preprints Share this article with Create alert Email: Submit > > > doi: 10.20944/preprints202005.0235.v1 Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed Impact of Gross Strap Muscle Invasion on Outcome of Differentiated (...) Thyroid Cancer: Systematic Review and Meta-Analysis , , , * , * , Version 1 : Received: 13 May 2020 / Approved: 14 May 2020 / Online: 14 May 2020 (11:35:41 CEST) How to cite: Zhang, L.; Liu, J.; Wang, P.; Xue, S.; Li, J.; Chen, G. Impact of Gross Strap Muscle Invasion on Outcome of Differentiated Thyroid Cancer: Systematic Review and Meta-Analysis. Preprints 2020 , 2020050235 (doi: 10.20944/preprints202005.0235.v1). Zhang, L.; Liu, J.; Wang, P.; Xue, S.; Li, J.; Chen, G. Impact of Gross Strap Muscle

2020 MDPI AG